Clinical Trial Update: Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update notes a study of sivelestat for postoperative organ protection in Type A aortic dissection, currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Dissection

Drugs mentioned

• Sivelestat (sivelestat)

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Type A Aortic Dissection, Organ Failure, Multiple | Phase 4 | Status: NOT_YET_RECRUITING